REAL-WORLD EFFECTIVENESS OF SOFOSBUVIR / VELPATASVIR/VOXILAPREVIR AS A HEPATITIS C VIRUS INFECTION SALVAGE TREATMENT

被引：0

作者：

Krajden, Mel ^{[1
]}

Cook, Darrel ^{[2
]}

Wong, Stanley ^{[2
]}

Wilton, James ^{[2
]}

Butt, Zahid Ahmad ^{[3
]}

Bartlett, Sofia ^{[2
]}

Pearce, Margo ^{[2
]}

Ramji, Alnoor ^{[4
]}

Yoshida, Eric M. ^{[5
]}

Yu, Amanda ^{[2
]}

Alvarez, Maria Jose ^{[2
]}

Binka, Mawuena ^{[3
]}

Janjua, Naveed ^{[2
,6
]}

机构：

[1] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC, Canada

[2] British Columbia Ctr Dis Control, Vancouver, BC, Canada

[3] Univ British Columbia, Vancouver, BC, Canada

[4] Univ British Columbia, Med, Vancouver, BC, Canada

[5] Univ British Columbia, Div Gastroenterol, Vancouver, BC, Canada

[6] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC, Canada

来源：

HEPATOLOGY | 2019年 / 70卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

1519

引用

页码：914A / 914A

页数：1

共 50 条

[31] Sofosbuvir/Velpatasvir/Voxilaprevir for Previous Treatment Failures With Glecaprevir/Pibrentasvir in Chronic Hepatitis C Infection
Pearlman, Brian
Perrys, Michael
Hinds, Andrew
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 (09): : 1550 - 1552
[32] Sofosbuvir/Velpatasvir/Voxilaprevir: A Review in Chronic Hepatitis C
Heo, Young-A
Deeks, Emma D.
DRUGS, 2018, 78 (05) : 577 - 587
[33] Patient-Reported Outcomes Following Treatment of Chronic Hepatitis C Virus Infection With Sofosbuvir and Velpatasvir, With or Without Voxilaprevir
Younossi, Zobair M.
Stepanova, Maria
Gordon, Stuart
Zeuzem, Stefan
Mann, Michael P.
Jacobson, Ira
Bourliere, Marc
Cooper, Curtis
Flamm, Steven
Reddy, K. Rajender
Kowdley, Kris
Younossi, Issah
Hunt, Sharon
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2018, 16 (04) : 567 - +
[34] Effectiveness of sofosbuvir/velpatasvir/voxilaprevir in patients with chronic hepatitis C virus infection and virologic failure to direct-acting antivirals
Ruiz-Boy, Sonia
Rodriguez-Reyes, Montserrat
Sotoca-Momblona, Jose Miguel
MEDICINA CLINICA, 2021, 157 (02): : 85 - 86
[35] Sofosbuvir/velpatasvir for patients with chronic hepatitis C virus infection and compensated liver disease: real-world data in Taiwan
Chen-Hua Liu
Po-Yueh Chen
Jyh-Jou Chen
Ching-Chu Lo
Wei-Wen Su
Kuo-Chih Tseng
Chun-Jen Liu
Chia-Sheng Huang
Ke-Jhang Huang
Sheng-Shun Yang
Cheng-Yuan Peng
Ming-Chang Tsai
Wei-Yu Kao
Chi-Yang Chang
Yu-Lueng Shih
Yu-Jen Fang
Chi-Yi Chen
Pei-Lun Lee
Jow-Jyh Huang
Pei-Yuan Su
Chi-Wei Tseng
Chien-Ching Hung
Chung-Hsin Chang
Yi-Jie Huang
Hsueh-Chou Lai
Chun-Chao Chang
Fu-Jen Lee
Tsai‐Yuan Hsieh
Jia-Horng Kao
Hepatology International, 2021, 15 : 338 - 349
[36] Sofosbuvir/velpatasvir for patients with chronic hepatitis C virus infection and compensated liver disease: real-world data in Taiwan
Liu, Chen-Hua
Chen, Po-Yueh
Chen, Jyh-Jou
Lo, Ching-Chu
Su, Wei-Wen
Tseng, Kuo-Chih
Liu, Chun-Jen
Huang, Chia-Sheng
Huang, Ke-Jhang
Yang, Sheng-Shun
Peng, Cheng-Yuan
Tsai, Ming-Chang
Kao, Wei-Yu
Chang, Chi-Yang
Shih, Yu-Lueng
Fang, Yu-Jen
Chen, Chi-Yi
Lee, Pei-Lun
Huang, Jow-Jyh
Su, Pei-Yuan
Tseng, Chi-Wei
Hung, Chien-Ching
Chang, Chung-Hsin
Huang, Yi-Jie
Lai, Hsueh-Chou
Chang, Chun-Chao
Lee, Fu-Jen
Hsieh, Tsai-Yuan
Kao, Jia-Horng
HEPATOLOGY INTERNATIONAL, 2021, 15 (02) : 338 - 349
[37] Final challenges: real-world experience with sofosbuvir, velpatasvir and voxilaprevir in patients with advanced cirrhosis
Papaluca, Tim
Roberts, Stuart
Strasser, Simone
Stuart, Katherine
New, Kate
Farrell, Geoff
Dore, Gregory
Wigg, Alan
Woodward, Aidan
Wade, Amanda
George, Jacob
Sinclair, Marie
McGarity, Bruce
Fisher, A. Leslie
Sawhney, Rohit
Wilson, Mark
Valiozis, Ivan
Levy, Miriam
Tse, Edmund
Ahlenstiel, Golo
Haque, Mazhar
Prewett, Emily
Sievert, William
Sood, Siddharth
O'Beirne, James
Thomas, James
Hazeldine, Simon
Valaydon, Zina
Douglas, Mark
Bowden, Scott
O'Keefe, Jacinta
Holmes, Jacinta
Thompson, Alexander
JOURNAL OF HEPATOLOGY, 2020, 73 : S363 - S363
[38] Real-life effectiveness and safety of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients with previous DAA failure
Degasperi, Elisabetta
Spinetti, Angiola
Lombardi, Andrea
Landonio, Simona
Rossi, Maria Cristina
Pasulo, Luisa
Pozzoni, Pietro
Giorgini, Alessia
Fabris, Paolo
Romano, Antonietta
Lomonaco, Lorenzo
Puoti, Massimo
Vinci, Maria
Gatti, Federico
Carolo, Giada
Zoncada, Alessia
Bonfanti, Paolo
Russo, Francesco Paolo
Aghemo, Alessio
Soria, Alessandro
Centenaro, Riccardo
Maggiolo, Franco
Rovere, Pierangelo
Pasin, Francesca
Paon, Veronica
Faggiano, Giovanni
Vario, Alessandro
Grossi, Glenda
Soffredini, Roberta
Carriero, Canio
Paolucci, Stefania
Noventa, Franco
Alberti, Alfredo
Lampertico, Pietro
Fagiuoli, Stefano
D'Ambrosio, Roberta
Degasperi, Elisabetta
Borghi, Marta
Perbellini, Riccardo
Gori, Andrea
Ferroni, Valentina
Pasulo, Luisa
Manini, Maria Colpani Matteo
Cologni, Giuliana
Lazzaroni, Sergio
Del Poggio, Paolo
Vinci, Maria
De Nicola, Stella
Mazzarelli, Chiara
Zucchetti, Teresa Angelini
JOURNAL OF HEPATOLOGY, 2019, 71 (06) : 1106 - 1115
[39] Sofosbuvir/Velpatasvir/Voxilaprevir Experience in Treatment-Naive Chronic Hepatitis C Patients: Preliminary Findings of Real World Data
Cakirca, Tuba Damar
Yamazhan, Tansu
Yuksekkaya, Esra
Akgul, Fethiye
Kurtaran, Behice
Karasahin, Omer
Karabay, Oguz
Unlu, Gulten
Can, Ilkay Nur
Pullukcu, Husnu
Tasova, Yesim
Komur, Suheyla
Yildiz, Yesim
Mermutluoglu, Cigdem
Demir, Yakup
Celen, Mustafa Kemal
VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL, 2023, 29 (02): : 58 - 63
[40] EARLY PLASMA AND INTRAHEPATIC HEPATITIS C VIRUS KINETICS DURING DAA TREATMENT WITH SOFOSBUVIR, VELPATASVIR, AND VOXILAPREVIR
Balagopal, Ashwin
Sachithanandham, Jaiprasath
Quinn, Jeffrey
Leep-Lazar, Julia
Bowden, Kenneth
Ward, Kathleen
Sulkowski, Mark S.
HEPATOLOGY, 2019, 70 : 981A - 982A

← 1 2 3 4 5 →